quote:
Op maandag 21 oktober 2013 12:18 schreef Japie77 het volgende:[..]
Gast...Er wordt toegegeven door Osterhaus en Coutinho dat er geen bewijs is dat het influenza vaccin werkt. Maar toch kan jij het wel vinden. Opmerkelijk. We hebben hier te maken met een nog grotere expert op het gebied van vaccinaties dan Osterhaus en Coutinho! Die zo maar wetenschappelijk bewijs van het internet kan toveren waar beide RIVM heren niet van op de hoogte zijn.....
2 experst ...
Noem er maar heel veel!
Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection 2004;32:199-203.
Ambrozaitis A, Gravenstein S, Van Essen GA, Rubinstein E, Balciuniene L, Stikleryte A, et al. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population. J Am Med Dir Assoc 2005;6:367-74.
Anonymus. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005;23:5133-43.
Belshe RB. The origins of pandemic influenza – lessons from the 1918 virus. N Engl J Med 2005;353:2209-11.
Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-96.
Bijl D. Bijwerkingen van oseltamivir (Tamiflu®). Gebu 2007;41:43.
Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284:1655-63.
Bueving HJ, Bernsen RM, De Jongste JC, Van Suijlekom-Smit LW, Rimmelzwaan GF, Osterhaus AD, et al. Does influenza vaccination exacerbate asthma in children? Vaccine 2004;23:91-6.
Bueving HJ, Thomas S, Van der Wouden JC. Influenza vaccination in children with asthma: no reason to change current recommendations. Am J Respir Crit Care Med 2005a;171:931-2.
Bueving HJ, Van der Wouden JC. Helpt influenzavaccinatie bij kinderen met astma? Huisarts Wet 2005b;48:670-3.
Buxton JA, Skowronski DM, Ng H, Marion SA, Li Y, King A, et al. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks. J Infect Dis 2001;184:188-91.
Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005;293:987-97.
Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93-7.
Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2005;CD000364.
Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med 2004;23:3469-87.
CBS. Overledenen naar belangrijke primaire doodsoorzaken. 2007a.
http://statline.cbs.nl, geraadpleegd 10 januari 2008.
CBS. Bevolking; kerncijfers naar diverse kenmerken. 2007b.
http://statline.cbs.nl, geraadpleegd 10 januari 2008.
Chan KH, Maldeis N, Pope W, Yup A, Ozinskas A, Gill J, et al. Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections. J Clin Microbiol 2002;40:1675-80.
Christy C, Aligne CA, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004;89:734-5.
Cools HJ, Van Essen GA. De richtlijn ‘Influenzapreventie in verpleeghuizen en verzorgingshuizen’ van de Nederlandse Vereniging van Verpleeghuisartsen; taakverdeling tussen verpleeghuisarts, huisarts en bedrijfsarts. Ned Tijdschr Geneeskd 2005;149:119-24.
Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994;12:993-9.
De Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, et al. Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 2006;24:1537-42.
Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2005;CD001269.
Dexter PR, Perkins SM, Maharry KS, Jones K, McDonald CJ. Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial. JAMA 2004;292:2366-71.
Diepersloot RJ. Influenza and diabetes: immunological and epidemiological aspects [proefschrift]. Rotterdam: Erasmus Universiteit, 1989.
Diepersloot RJ, Bouter KP, Hoekstra JB. Influenza infection and diabetes mellitus. Case for annual vaccination. Diabetes Care 1990;13:876-82.
Dijkstra F. Jaarrapportage respiratoire infectieziekten 2006/2007. Bilthoven: RIVM, 2007.
Donker G, Gravestein J. De beste tijd voor griepvaccinatie. Huisarts Wet 2007;50:41.
Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. JAMA 1961;176:776-82.
EISS (European Influenza Surveillance Scheme). EISS aims to contribute to a reduction in morbidity and mortality due to influenza in Europe. 2006.
http://www.eiss.org.
EISS Task group. EISS Task group on evaluation of the near patient test in influenza surveillance. Geneve: 2002.
EMEA (European Medicines Agency). Note for guidance on harmonization of requirements of influenza vaccines CPMP/BWP/214/96.
http://www.emea.europa.eu, geraadpleegd oktober 2007.
Gene J, Espinola A, Cabezas C, Boix C, Comin E, Martin A, et al. Do knowledge and attitudes about influenza and its immunization affect the likelihood of obtaining immunization? Fam Pract Res J 1992;12:61-73.
Gezondheidsraad. Griepvaccinatie: herziening van de indicatiestelling. Publicatienr 2007/9. Den Haag: Gezondheidsraad, 2007.
Glasgow JF, Middleton B. Reye syndrome – insights on causation and prognosis. Arch Dis Child 2001;85:351-3.
Goslings WR, Mulder J, Djajadiningrat J, Masurel N. Staphylococcal pneumonia in influenza in relation to antecedent staphylococcal skin infection. Lancet 1959;2:428-30.
Govaert ThM, Dinant GJ, Knottnerus JA. Vaccinatie tegen influenza in een huisartspraktijk. Opkomst en vaccinatiegraad van risicopatiënten. Huisarts Wet 1991;34:478-81.
Govaert ThM, Dinant GJ, Sprenger MJ, Aretz K, Masural N, Knottnerus JA. Geringe bijwerkingen van influenzavaccinatie bij ouderen: een gerandomiseerd dubbelblind placebogecontroleerd onderzoek. Ned Tijdschr Geneeskd 1994;138:2193-7.
Graffelman AW, Le Cessie S, Knuisting Neven A, Willemssen FE, Zonderland HM, Van den Broek PJ. Can history and exam alone reliably predict pneumonia? J Fam Pract 2007;56:465-70.
Gravenstein S, Drinka P, Osterweil D, Schilling M, Krause P, Elliott M, et al. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. J Am Med Dir Assoc 2005;6:359-66.
Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain-Barre syndrome following influenza vaccination. JAMA 2004;292:2478-81.
Hak E, Buskens E, Van Essen GA, De Bakker DH, Grobbee DE, Tacken MA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005;165:274-80.
Hamilton MS, Abel DM, Ballam YJ, Otto MK, Nickell AF, Pence LM, et al. Clinical evaluation of the ZstatFlu-II test: a chemiluminescent rapid diagnostic test for influenza virus. J Clin Microbiol 2002;40:2331-4.
Hayden F, Klimov A, Tashiro M, Hay A, Monto A, Kimm-Breschkin J, et al. Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther 2005;10:873-7.
Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.
Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004;189:440-9.
Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333:1241.
Hofstra ML, Ter Braak EM, Van der Werf GTh, Smith RJ. Een geautomatiseerd zoek- en oproepsysteem voor vaccinatie tegen influenza. Huisarts Wet 1990;33:432.
Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Kester AD, Rinkens PE, et al.Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358-64.
ICPC-2-NL. International Classification of Primary Care. Nederlandse versie. 2de ed. Utrecht: Nederlands Huisartsen Genootschap, 2000.
Jacobs JW, Creemers MC, Van Agtmael MA, Van de Laar MA, Van der Poll T, Tak PP, et al. TNF-blokkerende geneesmiddelen en infecties; adviezen voor de dagelijkse praktijk. Ned Tijdschr Geneeskd 2007;151:588-93.
Jansen AG, Sanders EA, Groen EJ, Van Loon AM, Hoes AW, Hak E. Schatting van de sterfte en ziektelast door het influenzavirus en het respiratoir syncytieel virus in Nederland gedurende 1997-2003: een epidemiologische benadering. Utrecht: Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde, 2007.
Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365:773-80.
Jefferson T, Demicheli V, Rivetti D, Jones M, Di PC, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-13.
Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667-72.
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, (ed.). Harrison’s principles of internal medicine, 16e ed. New York: McGraw-Hill, 2005.
Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001;138:306-10.
Labadie J, Van Grootheest AC. Meldingen van bijwerkingen van vaccins bij het Nederlands Bijwerkingen Centrum Lareb in 2004-2006. Ned Tijdschr Geneeskd 2007;151:2738-42.
Lareb. Schriftelijke mededeling. ’s-Hertogenbosch: Nederlands Bijwerkingen Centrum Lareb, 2007.
Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-8.
Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990;264:1139-41.
Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2005;CD002744.
Matsuzaki Y, Katsushima N, Nagai Y, Shoji M, Itagaki T, Sakamoto M, et al. Clinical features of influenza C virus infection in children. J Infect Dis 2006;193:1229-35.
McGovern MC, Glasgow JF, Stewart MC. Lesson of the week: Reye’s syndrome and aspirin: lest we forget. BMJ 2001;322:1591-2.
Meijboom M, Buskens E, Hak E. Influenza vaccinatie van gezonde volwassenen in de leeftijdscategorie 50-64; balans tussen kosten en effecten. Universitair Medisch Centrum, editor. Utrecht: Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde, 2007.
Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005;23:1004-14.
Ministerie VWS. Brief aan de voorzitter van de Tweede Kamer: Standpunt op advies Gezondheidsraad: ‘Griepvaccinatie: herziening van de indicatiestelling’. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport, 2007.
Montalto NJ. An office-based approach to influenza: clinical diagnosis and laboratory testing. Am Fam Physician 2003;67:111-8.
Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999;282:31-5.
Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.
Mulder J. Furunculose en staphylococcus-bronchopneumonie bij influenza. Ned Tijdschr Geneeskd 1956;100:2106-9.
Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005;23:2851-61.
Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333:889-93.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357:1373-81.
Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-45.
NIVEL. Continue morbiditeitsregistratie peilstations Nederland 1988/89. Utrecht: NIVEL, 1991.
Pachucki CT. The diagnosis of influenza. Semin Respir Infect 1992;7:46-53.
Potter J, Stott DJ, Roberts MA, Elder AG, O’Donnell B, Knight PV, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175:1-6.
Rastogi S, Gross PA, Bonelli J, Dran S, Levandowski RA, Russo C, et al. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol 1995;2:120-1.
Rimmelzwaan GF, De Jong JC, Donker GA, Meijer A, Fouchier RA, Osterhaus AD. Het influenzaseizoen 2005/’06 in Nederland en de vaccinsamenstelling voor het seizoen 2006/’07. Ned Tijdschr Geneeskd 2006;150:2209-14.
Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di PC, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006;3:CD004876.
RIVM/LCI. Draaiboeken influenzapandemie. Bilthoven: RIVM/LCI, 2006.
Rothbarth PH, Groen J, Bohnen AM, De Groot R, Osterhaus AD. Influenza virus serology – a comparative study. J Virol Methods 1999;78:163-9.
Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007;4:e59.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658-66.
Smits AJ, Hak E, Stalman WA, Van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 2002;128:205-11.
Sprenger MJW, Masurel N. Influenzavaccinatie en de Postbus 51 campagne. Ned Tijdschr Geneeskd 1992;136:1968-70.
Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993;22:334-40.
Stein J, Louie J, Flanders S, Maselli J, Hacker JK, Drew WL, et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med 2005;46:412-9.
Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003;28:225-32.
Swaan CM, Van der Sande MA, Speelman P, Conyn-van Spaandonk MA, Straus SM, Coutinho RA. Bijwerkingen na influenzavaccinatie: reactie op enkele incidenten en het belang van centrale registratie. Ned Tijdschr Geneeskd 2007;151:2166-9.
Tacken M, Braspenning J, Spreeuwenberg P, Van den Hoogen H, Van Essen GA, De Bakker DH, et al. Patient characteristics determine differences in the influenza vaccination rate more so than practice features. Prev Med 2002;35:401-6.
Tacken M, Mulder J, Van den Hoogen H, Donkers J, Tiersma W, Verheij R. Monitoring griepvaccinatiecampagne 2006. Utrecht: LINH-NIVEL, 2007.
Tacken MA, Braspenning JC, Berende A, Hak E, De Bakker DH, Groenewegen PP, et al. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine 2004;22:2985-92.
Thomas RE, Jefferson T, Demicheli V, Rivetti D. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 2006;3:CD005187.
Van Elden LJ, Nijhuis M, Schipper P, Schuurman R, Van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001;39:196-200.
Van Essen GA. Oproepen voor de influenzavaccinatie. Een regionale enquête. Huisarts Wet 1991;34:416-8.
Van Essen GA. Oproepen van alle 65-plussers voor de influenzavaccinatie. Een onderzoek in drie huisartspraktijken naar opkomst, motivatie en kennis. Huisarts Wet 1992;35:345-9.
Van Essen GA, Hak E, Verheij TJ. Voorbarige conclusie over effectiviteit griepprik bij kinderen. Huisarts Wet 2004;47:666.
Van Gageldonk-Lafeber AB, Heijnen ML, Bartelds AI, Peters MF, Van der Plas SM, Wilbrink B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis 2005;41:490-7.
Van Lidth de Jeude CP, Kuyvenhoven MM, De Melker RA. Multiple casefinding in een huisartspraktijk. Huisarts Wet 1991;34:546-50.
Verweij M, Dawson A. Ethical principles for collective immunisation programmes. Vaccine 2004;22:3122-6.
Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, Van der Lei J, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004;292:2089-95.
Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-54.
Weycker D, Edelsberg J, Halloran ME, Longini IM Jr, Nizam A, Ciuryla V, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005;23:1284-93.
WGBO. Wet op de geneeskundige behandelingsovereenkomst.
http://www.hulpgids.nl/wetten/wgbo.htm, geraadpleegd oktober 2007.
WHO. National Influenza Center.
http://www.virology.nl/index-influenza.htm.
Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.
Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;281:908-13.
WIP. Stichting Werkgroep Infectie Preventie.
http://www.wip.nl.